Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population

Running, not enrolling

Conditions studied: Activated Clotting Time

In brief

Measuring Activated Clotting Time (ACT) using the i-STAT ACTpro cartridge on the i-STAT 1 analyzer compared to a comparator device.

Key facts

Study ID

NCT07382076

Run by

Abbott Point of Care

People needed

500

Starts

2023-12-15

Expected to finish

2026-03-30

Last updated by the study team

2026-02-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is prescribed unfractionated heparin (UFH) peri-procedurally in order to reduce the risk of blood clots.
• OR
• Subject for which only the baseline specimen (prior to UFH administration) is collected, subject is admitted for a medical procedure that would or could typically necessitate the use of UFH to reduce the risk of blood clots.

You may not qualify if…

• Prior enrollment in the study.

Where it is running

• Dignity Health Chandler Regional Medical Center — Chandler, Arizona, United States
• University of California at San Francisco — San Francisco, California, United States
• George Washington University — Washington D.C., District of Columbia, United States
• Kentucky Clinical Trials Laboratory — Louisville, Kentucky, United States
• University of Maryland — Baltimore, Maryland, United States
• Minneapolis Heart Institute — Minneapolis, Minnesota, United States
• Washington University — St Louis, Missouri, United States
• Icahn School of Medicine at Mount Sinai — New York, New York, United States
• Penn State University Hershey Medical Center — Hershey, Pennsylvania, United States
• Thomas Jefferson University — Philadelphia, Pennsylvania, United States
• Eastside Research Associates - Redmond — Redmond, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.